Cannabis U.S. Companies

[GrooveMaster]

PAOG Announces Corporate Buyout & Opiate Addiction Inititative Toward Greater Shareholder Value, Quality of Care & Profitabil...
Date : 02/20/2018 @ 9:40AM
Source : InvestorsHub NewsWire
Stock : Pao Group, Inc. (PC) (PAOG)
Quote : 0.0079 0.0006 (8.22%) @ 4:00PM

PAOG Announces Corporate Buyout & Opiate Addiction Inititative Toward Greater Shareholder Value, Quality of Care & Profitabil...
Print
Alert


PAO Group, Inc. Announces Corporate Buyout Initiatives and Opiate Addiction Care Toward Greater Shareholder Value, Quality of Care and Overall Profitability

Sandusky, OH -- February 20, 2018 -- InvestorsHub NewsWire -- PAO Group, Inc. (OTC:PAOG), a physicians practice management company, focused on the proper use of cannabis for treatment of chronic, and terminal patients, announces today that, in analysis of details necessary to further expedite growth in shareholder value, the Company will begin streamlining operations in its Alternative Medicine Centers of America to exclusively include Corporate Owned facilities.

"It has always been the case that the Corporate owned facilities are more profitable than the affiliate locations," states CEO Robert Weber. "That said, the affiliate locations were a necessity in bootstrapping multiple locations and now that we have reached a sort of critical mass in both Ohio and Florida, the company is pleased to announce that we are now in the process of acquiring or replacing all of our existing affiliate locations to improve quality of patient services and overall profitability."

"We are also announcing our Grand Opening of new locations in Florida: Jacksonville, and St. Augustine. Jacksonville will open in early March, with St. Augustine to follow shortly thereafter. We are thrilled with the continued expansion of our brand, and services toward socially responsible profits, and overall success in our mission to provide communities and patients with the most efficacious solutions as an alternative measure to the pitfalls of opiate-based care," states Weber.

The Company is also pleased to announce that Alternative Medicine Centers of America will be launching opiate addiction treatment, beginning with its North Florida clinics.

"We are launching a pilot program in our North Florida clinics to offer opiate addiction treatment for indigent, and uninsured patients. Our sister company Rising Biosciences, Inc. was able to create an effective alternative compound for opiate addiction and will be making these available to indigent and uninsured patients in a comprehensive program including treatment via counseling, and medication to battle opioid addiction with an immediate discount for patients that facilitate affordable and responsible care. These discounts will also serve the company with significant tax benefits."

Alternative Medicine Centers of America provides health education, lifestyle coaching, and naturopathic medicine essential to an individual's successful achievement of personal wellness. Our success comes from providing patients with safe and confidential access to quality alternative healthcare, while providing them with the most professional support systems available. Alternative Medicine Centers of America provides the community and patient with the most current, innovative and dynamic wellness information and services possible. Alternative Medicine Centers of America brings to light personal wellness potential for patients and facilitates their journey to harmonious fitness.

Visit our website at: www.PAO.Group Contact us: [e-mail] or 1-888-PAO-Group "Like" and "Share" PAO Group on Facebook/paogroupinc and follow us on Twitter @paogroup
https://ih.advfn.com/p.php?pid=nmona&article=76755403&symbol=PAOG


RSII To Offer Cannophen to Patients in Ohio, Florida; Prepares for National Distribution of Scar Peptide Serum
Date : 02/20/2018 @ 9:45AM
Source : InvestorsHub NewsWire
Stock : Rising India Inc. (PC) (RSII)
Quote : 0.01088 0.00268 (32.68%) @ 3:59PM

RSII To Offer Cannophen to Patients in Ohio, Florida; Prepares for National Distribution of Scar Peptide Serum
Print
Alert


Rising Biosciences, Inc. To Offer Cannophen to Patients in Ohio, Florida; Launches Initiatives for National Distribution of Scar Peptide Serum

Sandusky, OH -- February 20, 2018 -- InvestorsHub NewsWire -- Rising India, Inc.'s (OTC: RSII) --Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that it will partner with PAO Group's (OTC: PAOG) Alternative Medicine Centers of America to offer a free trial of Cannophen to patients in the state of Ohio. Anyone with a valid Ohio recommendation can apply for the trial at our Ohio clinics; this will be done on a patient to patient basis.

Cannophen is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific terpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures.

"This is a monumental event for our company and one that means quite a bit to me personally," states COO Arthur Hall. " I have been using Cannophen since its earliest development stages in hopes to explore and discover its beneficial properties. Initially I was taking for symptoms of Parkinson's and was astounded by overall results: I had also been battling cancer for some time and through surgery, limited chemotherapy and the use of Cannophen I am now cancer free. My physicians are okay with the continued use of Cannophen for maintenance. We are grateful to be sharing this with other patients beginning with the program in Ohio I also will be meeting with a Producer/Processor in California next week that has demonstrated serious interest in licensing and distributing Cannophen and other Rising Biosciences products".

Mounting evidence shows 'cannabinoids' in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. According to The National Cancer Institute, Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow.

Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells. One notable study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that it damaged or killed the cancer cells. The same study of delta-9-THC in mouse models of liver cancer showed that it had antitumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.

As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products and is currently working with a company for national distribution of its Scar Peptide Serum.

Rising Biosciences Scar Peptide Serum



The following image depicts a patient who used the serum post-surgery to diminish scars, to astounding results:

Before and after surgery using Rising Bioscience's Scar Peptide Serum to diminish scars



"Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opioids on America through the responsible use of cannabis"



$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
https://ih.advfn.com/p.php?pid=nmona&article=76755454&symbol=RSII